文献速递肿瘤 PET/CT放射性药物与辐射防护

89Zr标记T细胞用于细胞追踪的检测限:基于临床PET/CT与PET/MRI的体外成像方法

Detection limit of 89Zr-labeled T cells for cellular tracking: an in vitro imaging approach using clinical PET/CT and PET/MRI.
PubMed 文献 · EJNMMI Res · 2020-07-14

本研究用不同比活度的[89Zr]Zr(oxinate)4标记Jurkat T细胞,在6孔板和1 cm³立方孔板中于临床PET/CT和PET/MRI成像,估算体外检测限。6孔板最低可检出6.8×10⁴个细胞(比活度27.8 kBq/10⁶细胞),立方孔板最低可检出3.3×10⁴个细胞(比活度15.4 kBq/10⁶细胞),作者认为该结果证明临床PET系统检测[89Zr]Zr(oxinate)4标记Jurkat T细胞具有可行性。

要点

  • 6孔板中最低可检出6.8×10⁴个细胞,对应比活度27.8 kBq/10⁶细胞。
  • 3×3立方孔板中最低可检出3.3×10⁴个细胞,对应比活度15.4 kBq/10⁶细胞。
  • 作者认为该体外结果属最佳情况,体内检测受细胞数、比活度、密度及非特异信号影响。

核心结论

  • 作者认为结果证明在临床PET系统上检测[89Zr]Zr(oxinate)4标记的Jurkat T细胞具有可行性。
  • 作者指出该结果提供的是最佳情况,体内PET/CT或PET/MRI检测会受细胞数、每细胞比活度、靶体积内细胞密度及非特异信号影响。
  • 作者认为该工作对患者细胞标记研究有重要意义,尤其是使用放射敏感细胞(如T细胞)时需在低细胞数检测与最小化每细胞辐射剂量之间权衡。

研究设计与样本

  • 体外研究:用不同浓度[89Zr]Zr(oxinate)4标记Jurkat T细胞,产生0.43–31.91 kBq/10⁶细胞的细胞比活度。
  • 将10⁴、10⁵和10⁶个标记细胞接种于6孔板及含1 cm³立方孔的3×3立方孔板(凝胶基质)中。
  • 在临床PET/CT和PET/MRI扫描仪上成像30分钟,通过在各孔上勾画感兴趣体积测定总活度。
  • 用井型计数器测定细胞相关总活度并与影像数据关联,另进行非特异信号模拟以建模非特异放射性对检测的影响。

主要发现

  • 6孔板图像中可可视化的最低细胞数为6.8×10⁴个,当时比活度为27.8 kBq/10⁶细胞。
  • 3×3立方孔板图像中可检测到3.3×10⁴个细胞,当时比活度为15.4 kBq/10⁶细胞。

局限性

  • 作者指出该结果提供的是最佳情况,体内PET/CT或PET/MRI检测会受细胞数、每细胞比活度、靶体积内细胞密度及非特异信号影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Tracking cells in vivo using imaging can provide non-invasive information to understand the pharmacology, efficacy, and safety of novel cell therapies. Zirconium-89 (t1/2 = 78.4 h) has recently been used to synthesize [89Zr]Zr(oxinate)4 for cell tracking using positron emission tomography (PET). This work presents an in vitro approach to estimate the detection limit for in vivo PET imaging of Jurkat T cells directly labeled with [89Zr]Zr(oxinate)4 utilizing clinical PET/CT and PET/MRI. METHODS: Jurkat T cells were labeled with varying concentrations of [89Zr]Zr(oxinate)4 to generate different cell-specific activities (0.43-31.91 kBq/106 cells). Different concentrations of labeled cell suspensions (104, 105, and 106 cells) were seeded on 6-well plates and into a 3 × 3 cubic-well plate with 1 cm3 cubic wells as a gel matrix. Plates were imaged on clinical PET/CT and PET/MRI scanners for 30 min. The total activity in each well was determined by drawing volumes of interest over each well on PET images. The total cell-associated activity was measured using a well counter and correlated with imaging data. Simulations for non-specific signal were performed to model the effect of non-specific radioactivity on detection. RESULTS: Using this in vitro model, the lowest cell number that could be visualized on 6-well plate images was 6.8 × 104, when the specific activity was 27.8 kBq/106 cells. For the 3 × 3 cubic-well, a plate of 3.3 × 104 cells could be detected on images with a specific activity of 15.4 kBq/106 cells. CONCLUSION: The results show the feasibility of detecting [89Zr]Zr(oxinate)4-labeled Jurkat T cells on clinical PET systems. The results provide a best-case scenario, as in vivo detection using PET/CT or PET/MRI will be affected by cell number, specific activity per cell, the density of cells within the target volume, and non-specific signal. This work has important implications for cell labeling studies in patients, particularly when using radiosensitive cells (e.g., T cells), which require detection of low cell numbers while minimizing radiation dose per cell.

来源:EJNMMI Res,查看原文。版权归原作者所有。

引用

  1. Lechermann LM, Manavaki R, Attili B, et al. Detection limit of 89Zr-labeled T cells for cellular tracking: an in vitro imaging approach using clinical PET/CT and PET/MRI. EJNMMI Res. 2020. PMID: 32666311. doi:10.1186/s13550-020-00667-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。